Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment
Raoul Belzeaux, Laura M. Fiori, Juan Pablo López, et al.
The Journal of Clinical Psychiatry (2019) Vol. 80, Iss. 3
Open Access | Times Cited: 20

Showing 20 citing articles:

Clinical Insights into MicroRNAs in Depression: Bridging Molecular Discoveries and Therapeutic Potential
Lalit Kaurani
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2866-2866
Open Access | Times Cited: 9
The miRNome of Depression
Dariusz Żurawek, Gustavo Turecki
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11312-11312
Open Access | Times Cited: 42
Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior
Bhaskar Roy, Shinichiro Ochi, Yogesh Dwivedi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4664-4664
Open Access | Times Cited: 18
Suicide Biomarkers to Predict Risk, Classify Diagnostic Subtypes, and Identify Novel Therapeutic Targets: 5 Years of Promising Research
Jenessa N. Johnston, Darcy Campbell, Héctor J. Caruncho, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 25, Iss. 3, pp. 197-214
Open Access | Times Cited: 29
Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key Pathways
Masaki Kato, Haruhiko Ogata, Hidetoshi Tahara, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3873-3873
Open Access | Times Cited: 17
Identifying Immune Response Protein Biomarkers in Parkinson’s-Related Cognitive Impairment and Depression
Qiaozhen Su, Ting Lu, Yan Xu, et al.
Molecular Neurobiology (2025)
Closed Access
Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis
Toshiya Funatsuki, Haruhiko Ogata, Hidetoshi Tahara, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12199-12199
Open Access | Times Cited: 6
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review
Claudia Pisanu, Giovanni Severino, Ilario De Toma, et al.
European Neuropsychopharmacology (2022) Vol. 55, pp. 112-157
Closed Access | Times Cited: 10
Biomarkers for Suicidal Behavior: miRNAs and their Potential for Diagnostics through Liquid Biopsy – a Systematic Review
Katarina Kouter, Alja Videtič Paska
Epigenomics (2020) Vol. 12, Iss. 24, pp. 2219-2235
Open Access | Times Cited: 14
Telomeres: the role of shortening and senescence in major depressive disorder and its therapeutic implications
Jéssica Daniela Schröder, Julia Beatrice de Araújo, Tácio de Oliveira, et al.
Reviews in the Neurosciences (2021) Vol. 33, Iss. 3, pp. 227-255
Closed Access | Times Cited: 11
The molecular pathophysiology of mood disorders: From the analysis of single molecular layers to multi-omic integration
Amazigh Mokhtari, Baptiste Porte, Raoul Belzeaux, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 116, pp. 110520-110520
Open Access | Times Cited: 8
MicroRNAs as potential biomarkers for diagnosis of major depressive disorder and influence of antidepressant treatment
Bridget Martinez, Philip V. Peplow
NeuroMarkers. (2024) Vol. 1, Iss. 1, pp. 100001-100001
Open Access | Times Cited: 1
Troubling Neurobiological Vulnerability: Psychiatric Risk and the Adverse Milieu in Environmental Epigenetics Research
Ângela Marques Filipe, Stephanie Lloyd, Alexandre Larivée
Frontiers in Sociology (2021) Vol. 6
Open Access | Times Cited: 8
Epigenetic studies in suicidal ideation and behavior
Oluwagbenga Dada, Jessica Qian, Nzaar Al-Chalabi, et al.
Psychiatric Genetics (2021) Vol. 31, Iss. 6, pp. 205-215
Closed Access | Times Cited: 6
Transcriptomic Studies of Antidepressant Action in Rodent Models of Depression: A First Meta-Analysis
El Chérif Ibrahim, Victor Gorgievski, Pilar Ortiz-Teba, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13543-13543
Open Access | Times Cited: 4
MicroRNAs as novel peripheral markers for suicidality in patients with major depressive disorder
Britta Stapel, Ke Xiao, Nataliya Gorinski, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 4
Peripheral Biomarkers and Suicide: The Role of Neurotransmission, Neurotrophism, Neuroinflammation, and Neuroplasticity Dysregulation
Donato Morena, Emanuela Turillazzi, Vittorio Fineschi
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 10
Open Access
Emerging role of microRNAs as novel targets of antidepressants
Aarthi Manoharan, Abialbon Paul
Asian Journal of Psychiatry (2021) Vol. 66, pp. 102906-102906
Closed Access | Times Cited: 2
Changes in RNA expression levels during antidepressant treatment: a systematic review
Helena Kyunghee Kim, Gwyneth Zai, Johannes M. Hennings, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 9, pp. 1461-1477
Closed Access | Times Cited: 1
The molecular pathophysiology of mood disorders: from the analysis of single molecular layers to multi-omic integration.
Amazigh Mokhtari, Baptiste Porte, Raoul Belzeaux, et al.
(2021)
Open Access
Page 1

Scroll to top